Long-Term and Memory Immune Responses in Mice against Newcastle Disease Virus-Like Particles Containing Respiratory Syncytial Virus Glycoprotein Ectodomains-Reference-Cited by-同舟云学术

Long-Term and Memory Immune Responses in Mice against Newcastle Disease Virus-Like Particles Containing Respiratory Syncytial Virus Glycoprotein Ectodomains

Published:2012-08-15 Issue:21 Volume:86 Page:11654-11662
ISSN:0022-538X
Container-title:Journal of Virology
language:en
Short-container-title:Journal of Virology

Author:

Schmidt M. R.,McGinnes L. W.,Kenward S. A.,Willems K. N.,Woodland R. T.,Morrison T. G.

Publisher

American Society for Microbiology

Subject

Virology,Insect Science,Immunology,Microbiology

Reference47 articles.

1. Cutting edge: IL-21 and TLR signaling regulate germinal center responses in a B cell-intrinsic manner;Bessa;J. Immunol.,2010

2. T cell-independent B cell memory;Defrance;Curr. Opin. Immunol.,2011

3. Lack of antibody affinity maturation due to poor Toll-like receptor stimulation leads to enhanced respiratory syncytial virus disease;Delgado;Nat. Med.,2009

4. Naive T-cell receptor transgenic T cells help memory B cells produce antibody;Duffy;Immunology,2006

5. Respiratory syncytial virus infection in elderly and high-risk adults;Falsey;N. Engl. J. Med.,2005

Cited by 45 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Design and Preclinical Evaluation of a Nanoparticle Vaccine against Respiratory Syncytial Virus Based on the Attachment Protein G;Vaccines;2024-03-12

2. Respiratory Viruses and Virus-like Particle Vaccine Development: How Far Have We Advanced?;Viruses;2023-01-30

3. Virus-like particles containing a prefusion-stabilized F protein induce a balanced immune response and confer protection against respiratory syncytial virus infection in mice;Frontiers in Immunology;2022-12-12

4. mRNA vaccines: A novel weapon to control infectious diseases;Frontiers in Microbiology;2022-10-04

5. Immunoinformatics-Aided Analysis of RSV Fusion and Attachment Glycoproteins to Design a Potent Multi-Epitope Vaccine;Vaccines;2022-08-24